This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: E Roy Pettipher: Innovator in Tissue Damage Reduction
Introduction
E Roy Pettipher is a notable inventor based in Norwich, CT (US). He has made significant contributions to the field of medical science, particularly in methods aimed at reducing tissue damage associated with ischemia. With a total of 2 patents, Pettipher's work has the potential to impact patient care positively.
Latest Patents
Pettipher's latest patents include a "Method of reducing tissue damage associated with non-cardiac ischemia." This method involves administering an effective amount of an aldose reductase inhibitor to prevent non-cardiac tissue damage resulting from ischemia. Another significant patent is the "Method of reducing tissue damage associated with ischemia," which focuses on administering a sorbitol dehydrogenase inhibitor to patients in need of treatment.
Career Highlights
E Roy Pettipher is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to explore innovative solutions to complex medical challenges. His research and inventions are aimed at improving patient outcomes and advancing medical knowledge.
Collaborations
Pettipher has collaborated with esteemed colleagues such as Peter J Oates and Thomas A Beyer. These collaborations have fostered a productive environment for innovation and have contributed to the development of his patents.
Conclusion
E Roy Pettipher's contributions to the field of medical science through his patents demonstrate his commitment to improving healthcare. His innovative methods for reducing tissue damage associated with ischemia highlight the importance of research and collaboration in advancing medical treatments.